2. resources & tools
  3. reference library

NAROPIN Reference Library

Use the following links to access the PubMed references for the studies referenced within this site.

LABOR EPIDURALS

SIGNIFICANTLY LESS MOTOR BLOCK

Aşik I, Göktuğ A, Gülay I, Alkiş N, Uysalel A. Comparison of bupivacaine 0.2% and ropivacaine 0.2% combined with fentanyl for epidural analgesia during labour. Eur J Anaesthesiol. 2002;19:263-270.

http://www.ncbi.nlm.nih.gov/pubmed/12074415

Writer WDR, Stienstra R, Eddleston JM, et al. Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis. Br J Anaesth. 1998;81:713-717.

http://www.ncbi.nlm.nih.gov/pubmed/10193281

HIGHER PROPORTION OF SPONTANEOUS DELIVERIES

Writer WDR, Stienstra R, Eddleston JM, et al. Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis. Br J Anaesth. 1998;81:713-717.

http://www.ncbi.nlm.nih.gov/pubmed/10193281

NAROPIN Prescribing Information. Data on file.

Download PDF

SIGNIFICANTLY FEWER INSTRUMENTED DELIVERIES

Aşik I, Göktuğ A, Gülay I, Alkiş N, Uysalel A. Comparison of bupivacaine 0.2% and ropivacaine 0.2% combined with fentanyl for epidural analgesia during labour. Eur J Anaesthesiol. 2002;19:263-270.

http://www.ncbi.nlm.nih.gov/pubmed/12074415

Writer WDR, Stienstra R, Eddleston JM, et al. Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis. Br J Anaesth. 1998;81:713-717.

http://www.ncbi.nlm.nih.gov/pubmed/10193281

NAROPIN Prescribing Information. Data on file.

Download PDF

PERIPHERAL NERVE BLOCKS

FASTER RETURN OF MOTOR FUNCTION: LOWER BODY

Morrison LM, Emanuelsson BM, McClure JH, et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine. Br J Anaesth. 1994;72:164-169.

http://www.ncbi.nlm.nih.gov/pubmed/8110567

FASTER RETURN OF MOTOR FUNCTION: UPPER BODY

McGlade DP, Kalpokas MV, Mooney PH, et al. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesth Intensive Care. 1998;26:515-520.

http://www.ncbi.nlm.nih.gov/pubmed/9807606

FASTER RETURN OF MOTOR FUNCTION: C-SECTIONS

Datta S, Camann W, Bader A, VanderBurgh L. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology. 1995;82:1346-1352.

http://www.ncbi.nlm.nih.gov/pubmed/7793647

Griffin RP, Reynolds F. Extradural anaesthesia for caesarean section: a double-blind comparison of 0.5% ropivacaine with 0.5% bupivacaine. Br J Anaesth. 1995;74:512-516.

http://www.ncbi.nlm.nih.gov/pubmed/7772423

Crosby E, Sandler A, Finucane B, et al. Comparison of epidural anaesthesia with ropivacaine 0.5% and bupivacaine 0.5% for caesarian section. Can J Anaesth. 1998;45:1066-1071.

http://www.ncbi.nlm.nih.gov/pubmed/10021954

EFFECTIVE ANALGESIA

SIMILAR ONSET AND DURATION, AND EFFECTIVE SENSORY BLOCK

McGlade DP, Kalpokas MV, Mooney PH, et al. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesth Intensive Care. 1998;26:515-520.

http://www.ncbi.nlm.nih.gov/pubmed/9807606

Morrison LM, Emanuelsson BM, McClure JH, et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine. Br J Anaesth. 1994;72:164-169.

http://www.ncbi.nlm.nih.gov/pubmed/8110567

Beaulieu P, Babin D, Hemmerling T. The pharmacodynamics of ropivacaine and bupivacaine in combined sciatic and femoral nerve blocks for total knee arthroplasty. Anesth Analg. 2006;103:768-774.

http://www.ncbi.nlm.nih.gov/pubmed/16931694

Hickey R, Hoffman J, Ramamurthy S. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. Anesthesiology. 1991;74:639-642.

http://www.ncbi.nlm.nih.gov/pubmed/2008942

SIGNIFICANT REDUCTION IN THE NEED FOR OPIOIDS

NAROPIN Prescribing Information. Data on file.

Download PDF

Bertini L, Tageriello V, Mancini S, et al. 0.75% and 0.5% ropivacaine for axillary brachial plexus block: a clinical comparison with 0.5% bupivacaine. Reg Anesth Pain Med. 1999;24:514-518.

http://www.ncbi.nlm.nih.gov/pubmed/10588554

SIGNIFICANTLY MORE PATIENTS WERE SATISFIED WITH ANALGESIC EFFICACY

Bertini L, Tageriello V, Mancini S, et al. 0.75% and 0.5% ropivacaine for axillary brachial plexus block: a clinical comparison with 0.5% bupivacaine. Reg Anesth Pain Med. 1999;24:514-518.

http://www.ncbi.nlm.nih.gov/pubmed/10588554

Bertini L, Mancini S, Di Benedetto P, et al. Postoperative analgesia by combined continuous infusion and patient-controlled epidural analgesia (PCEA) following hip replacement: ropivacaine versus bupivacaine. Acta Anaesthesiol Scand. 2001;45:782-785.

http://www.ncbi.nlm.nih.gov/pubmed/11421841

ADEQUATE AND EQUIVALENT SENSORY ANESTHESIA

Datta S, Camann W, Bader A, VanderBurgh L. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology. 1995;82:1346-1352.

http://www.ncbi.nlm.nih.gov/pubmed/7793647

Griffin RP, Reynolds F. Extradural anaesthesia for caesarean section: a double-blind comparison of 0.5% ropivacaine with 0.5% bupivacaine. Br J Anaesth. 1995;74:512-516.

http://www.ncbi.nlm.nih.gov/pubmed/7772423

Crosby E, Sandler A, Finucane B, et al. Comparison of epidural anaesthesia with ropivacaine 0.5% and bupivacaine 0.5% for caesarian section. Can J Anaesth. 1998;45:1066-1071.

http://www.ncbi.nlm.nih.gov/pubmed/10021954

SAFETY & TOLERABILITY

SIGNIFICANTLY BETTER CARDIOVASCULAR AND CNS PROFILE

Scott DB, Lee A, Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69:563-569.

http://www.ncbi.nlm.nih.gov/pubmed/2679230

Knudsen K, Beckman SM, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507-514.

http://www.ncbi.nlm.nih.gov/pubmed/9175963

SIGNIFICANTLY FEWER CARDIOVASCULAR SIDE EFFECTS

Scott DB, Lee A, Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69:563-569.

http://www.ncbi.nlm.nih.gov/pubmed/2679230

Knudsen K, Beckman SM, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507-514.

http://www.ncbi.nlm.nih.gov/pubmed/9175963

LOWER RISK OF SYSTEMIC TOXICITY THAN BUPIVACAINE

Scott DB, Lee A, Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69:563-569.

http://www.ncbi.nlm.nih.gov/pubmed/2679230

Knudsen K, Beckman SM, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507-514.

http://www.ncbi.nlm.nih.gov/pubmed/9175963

Lee A, Fagan D, Lamont M, Tucker GT, Halldin M, Scott DB. Disposition kinetics of ropivacaine in humans. Anesth Analg. 1989;69:736-738.

http://www.ncbi.nlm.nih.gov/pubmed/2589653

Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology. 1979;51:285-287.

http://www.ncbi.nlm.nih.gov/pubmed/484889

MORE FAVORABLE PREGNANCY CATEGORY B

NAROPIN Prescribing Information. Data on file.

Download PDF

Sensorcaine [package insert]. Lake Zurich, IL: Fresenius Kabi USA, LLC; 2009.

Download PDF

PHARMACOLOGIC PROFILE

Beaulieu P, Babin D, Hemmerling T. The pharmacodynamics of ropivacaine and bupivacaine in combined sciatic and femoral nerve blocks for total knee arthroplasty. Anesth Analg. 2006;103:768-774.

http://www.ncbi.nlm.nih.gov/pubmed/16931694

Bertini L, Tageriello V, Mancini S, et al. 0.75% and 0.5% ropivacaine for axillary brachial plexus block: A clinical comparison with 0.5% bupivacaine. Reg Anesth Pain Med. 1999;24:514-518.

http://www.ncbi.nlm.nih.gov/pubmed/10588554

Hansen TG. Ropivacaine: a pharmacological review. Expert Rev Neurother. 2004;4:781-791.

http://www.ncbi.nlm.nih.gov/pubmed/15853505

Knudsen K, Beckman SM, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507-514.

http://www.ncbi.nlm.nih.gov/pubmed/9175963

McGlade DP, Kalpokas MV, Mooney PH, Chamley D, Mark AH, Torda TA. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesth Intensive Care. 1998;26:515-520.

http://www.ncbi.nlm.nih.gov/pubmed/9807606

Scott DB, Lee A, Fagan D, Bowler GMR, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69:563-569.

http://www.ncbi.nlm.nih.gov/pubmed/2679230

Zaric D, Nydahl P-A, Phillipson L, Samuelsson L, Heierson A, Axelsson K. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2%, 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers: a double-blind study. Reg Anesth. 1996;21:14-25.

http://www.ncbi.nlm.nih.gov/pubmed/8826020

Important Safety Information

Using NAROPIN beyond recommended doses to increase motor block or duration of sensory block may negate its favorable cardiovascular advantages, in the event that an inadvertent intravascular injection occurs. NAROPIN may be associated with adverse reactions which are characteristic of those associated with other amide-type local anesthetics.1 In clinical trials, side effects were mild and transient and may reflect the procedures, patient health status, and/or other medications used. Adverse events reported at a rate of ≥5%: hypotension, nausea, vomiting, bradycardia, fever, pain, postoperative complications, anemia, paresthesia, headache, pruritus, and back pain.

There have been adverse event reports of chondrolysis in patients receiving intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures. NAROPIN is not approved for this use.

Please see Full Prescribing Information.

1. NAROPIN Prescribing Information Data on file.

NAROPIN is indicated for the production of local or regional anesthesia for surgery and acute pain management.

NAROPIN and logo are registered trademarks of Fresenius Kabi USA, LLC. ©2015, Fresenius Kabi USA, LLC. All Rights Reserved.